A 35-year-old man with a history of schizophrenia is brought to the emergency department from a residential psychiatric facility due to high fever, severe muscle rigidity, and progressive confusion over the past 24 hours. His current medication regimen includes high-dose fluphenazine. His temperature is 39.8°C (103.6°F), blood pressure is 168/104 mm Hg, and pulse is 122/min. Physical examination reveals generalized lead-pipe rigidity and profuse diaphoresis. Laboratory studies show a markedly elevated creatine kinase level. Arrange the following interventions in the most appropriate sequential order for the standard step-wise management of this patient's condition, from the initial immediate action to the last-resort treatment.
- 1Discontinue the offending antipsychotic medication
- 2Initiate intensive supportive care with intravenous fluids and cooling measures
- 3Administer targeted pharmacotherapy such as bromocriptine or dantrolene
- 4Consider electroconvulsive therapy (ECT)
Answer
The correct sequential order for managing Neuroleptic Malignant Syndrome (NMS) is: 1) Discontinue the offending antipsychotic medication, 2) Initiate intensive supportive care with intravenous fluids and cooling measures, 3) Administer targeted pharmacotherapy such as bromocriptine or dantrolene, and 4) Consider electroconvulsive therapy (ECT).
The management of neuroleptic malignant syndrome (NMS) follows a specific, step-wise protocol based on clinical severity and response. The absolute first and most essential step is to discontinue the offending dopamine antagonist. Immediately following this, the mainstay of early management is aggressive supportive care, which includes substantial intravenous hydration to flush myoglobin and prevent acute kidney injury, alongside cooling blankets to manage hyperthermia. If the patient does not demonstrate adequate clinical improvement with these initial conservative measures, the next step is to initiate specific pharmacotherapy, such as bromocriptine (a dopamine agonist to overcome the blockade) or dantrolene (a ryanodine receptor antagonist to relax skeletal muscle). Finally, in severe, life-threatening cases that remain refractory to all medical interventions, electroconvulsive therapy (ECT) is considered as the definitive treatment.
Step-by-Step Solution
Key Concept
The step-wise management of Neuroleptic Malignant Syndrome prioritizes stopping the offending agent, followed by supportive care, targeted medications, and finally ECT.